331253-86-2 Usage
Uses
Used in Oncology:
PDK1/Akt/Flt Dual Pathway Inhibitor is used as an anticancer agent for targeting the PDK1, Akt, and Flt signaling pathways, which are commonly dysregulated in various types of cancer. By inducing apoptosis in cancer cells, this inhibitor can potentially halt tumor growth and progression, offering a novel therapeutic approach for cancer treatment.
Used in Drug Development:
PDK1/Akt/Flt Dual Pathway Inhibitor can be utilized in the development of new drugs targeting cancer cells with dysregulated PDK1, Akt, and Flt pathways. Its cell-permeable nature and selective induction of apoptosis make it a valuable compound for designing targeted cancer therapies.
Used in Preclinical Research:
In the field of preclinical research, PDK1/Akt/Flt Dual Pathway Inhibitor can be employed to study the effects of inhibiting these pathways on cancer cell behavior, including cell proliferation, survival, and apoptosis. This can provide valuable insights into the mechanisms of action and potential therapeutic applications of PDK1/Akt/Flt Dual Pathway Inhibitor in cancer treatment.
Used in Drug Combination Strategies:
PDK1/Akt/Flt Dual Pathway Inhibitor can be explored for its potential synergistic effects when combined with other anticancer agents. By targeting multiple signaling pathways simultaneously, PDK1/Akt/Flt Dual Pathway Inhibitor may enhance the efficacy of existing treatments and overcome drug resistance in cancer cells.
Used in Personalized Medicine:
The PDK1/Akt/Flt Dual Pathway Inhibitor can be investigated for its potential role in personalized medicine, where treatments are tailored to individual patients based on their specific genetic and molecular profiles. By targeting specific dysregulated pathways in cancer cells, this inhibitor may offer a more targeted and effective treatment option for patients with specific genetic mutations or pathway alterations.
Check Digit Verification of cas no
The CAS Registry Mumber 331253-86-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,1,2,5 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 331253-86:
(8*3)+(7*3)+(6*1)+(5*2)+(4*5)+(3*3)+(2*8)+(1*6)=112
112 % 10 = 2
So 331253-86-2 is a valid CAS Registry Number.
331253-86-2Relevant academic research and scientific papers
Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
-
Page/Page column 18-19, (2008/12/04)
The present invention concerns new compounds of formula (I), their process of preparation and their therapeutic use wherein R3, R4, R5, R6, Y, Het1, T, U, V, W, X, Ru, Rv and Rw are as defined in claim 1
